Dr. Brodersen received her PHD from the chemistry department at the University of Washington in Seattle. She transitioned to clinical laboratory medicine, completing her post-doctoral training with Drs’ Loken, Wells, and Zehentner at Hematologics. Dr. Brodersen’s training is in utilizing flow cytometry as a diagnostic tool in hematologic malignancies, with additional training in molecular analysis. She has extensively trained with Dr. Loken in residual disease detection of AML and ALL. Antigen expression in normal individuals, the regulation of amounts of gene products, and tumor heterogeneity in pediatric AML are her primary research interests.